New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation

Background: Survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has increased but so have long-term sequelae. New-onset post-transplant diabetes mellitus (PTDM) occurs frequently following allo-HSCT.  Patients and Methods: Study endpoints were incidence and risk factors of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:In Vivo
Autors principals: DALLA VIA, VERA, HALTER, P. JÖRG, GERULL, SABINE, ARRANTO, CHRISTIAN, TICHELLI, ANDRÉ, HEIM, DOMINIK, PASSWEG, R. JAKOB, MEDINGER, MICHAEL, CESANA-NIGRO, NICOLE
Format: Artigo
Idioma:Inglês
Publicat: International Institute of Anticancer Research 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7811658/
https://ncbi.nlm.nih.gov/pubmed/33144466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12197
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars